AMZ001 for the Treatment of Knee Osteoarthritis Symptoms

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

444

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

July 9, 2019

Study Completion Date

July 9, 2019

Conditions
Osteoarthritis, Knee
Interventions
DRUG

AMZ001

diclofenac gel

DRUG

Placebo

Placebo

DRUG

Comparator

diclofenac gel

Trial Locations (7)

14221

Upstate Clinical Research Associates, Williamsville

32162

Premier Medical Associates, The Villages

06460

Clinical Research Consulting, Milford

Unknown

CCR Brno, s.r.o, Brno

CCR Czech, a.s, Pardubice

CCR Prague s.r.o., Prague

Sanos Clinic, Herlev

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Amzell

INDUSTRY

NCT03691844 - AMZ001 for the Treatment of Knee Osteoarthritis Symptoms | Biotech Hunter | Biotech Hunter